NASDAQ$NUTX

Nutex Health Inc · Q2 2023 earnings

Q2 2023 earnings ·

Headline financials

Total Revenue

$58.9M

Previous: $58M+1.5%
EPS

-$0.01

Previous: -$0.03+66.7%
Capital Expenditures

-$3.07M

Previous: -$16.6M+81.5%
Free Cash Flow

-$6.55M

Previous: -$40.1M+83.7%
Net Income

-$3.48M

Previous: -$23.5M+85.2%
Operating Income

-$363K

Previous: -$1.38M+73.7%
Gross Profit

$9.65M

Previous: $4.99M+93.2%
Cash & Equivalents

$32.8M

Previous: $47.6M-31.2%
Total Assets

$436M

Previous: $872M-50.0%

Revenue & EPS history

Nutex Health Inc · Revenue · Quarterly

$58.9M

Q2 2023+1.5%vs Q2 2022
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

+1.9%

Avg return

Earnings day

+17.2%

Avg return

5 days after

+21.1%

Avg return

30 days after

62%

8 / 13 earnings

Positive

+22.4%

Q1 2022

Best reaction

-14.3%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.4%+8.0%+14.4%
Q4 2025-14.3%-14.1%-4.2%
Q3 2025+0.0%+32.9%+64.1%
Q1 2025+1.0%+40.2%+0.2%
Q3 2024+6.3%+38.2%+39.3%
Q2 2024+0.9%+62.7%+173.1%
Q1 2024+6.2%+14.8%+0.7%
Q3 2023+0.0%-6.0%-22.8%
Q2 2023+3.6%+0.9%-20.1%
Q1 2023+8.9%+10.3%-17.8%
Q3 2022-9.2%+1.7%+59.7%
Q2 2022-8.2%-27.9%-53.8%
Q1 2022+22.4%+61.8%+41.2%
Q3 2021
Q2 2021
Q1 2021
Q3 2020
Q1 2020
Q3 2019
Q1 2019
Q2 2018
Q2 2016
Q3 2014
Q1 2014
Q3 2013
Q2 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro